NEWS | May 15, 2019

In the spotlight: 'The answer to the opioid crisis?'

The Sacramento Bee highlights a promising, non-addictive alternative to opioids being developed by a UC Davis professor

(SACRAMENTO)

A recent Sacramento Bee story highlighted UC Davis progress on a new drug for chronic pain that, if successful in human trials, might help replace the addictive medications at the center of the country's opioid epidemic.

The <em>Sacramento Bee</em> explored UC Davis research on a new pain   drug in a recent article, noting its potential to help ease the opioid crisis. The Sacramento Bee explored UC Davis research on a new pain drug in a recent article, noting its potential to help ease the opioid crisis.

The novel medication being developed by Bruce Hammock, an entomologist with an appointment at the National Cancer Institute-designated UC Davis Comprehensive Cancer Center, has been reported both effective and non-addictive so far in animal trials. 

Hammock, a member of the National Academy of Inventors, expects the new drug to enter human trials this fall. So far related clinical studies have received more than $4 million in federal support, as well as a $5 million commitment from the nonprofit Open Philanthropy Project.

Collaboration between human and animal health scientists is a unique hallmark of research at UC Davis, home to a related One Health Institute

Read more:
'The answer to opioid crisis? UC Davis researcher will soon test his non-addictive pain drug'
Sacramento Bee, April 29, 2019